4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-043678
SVP and General Counsel sold 2,880 shares at $36.03 ($103,766)
- SVP and General Counsel acquired 2,880 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2020-07-24 | Option exercise | +1,109 | $7.80 | $8,650 | 2,409 | D: show line 1 in the form |
| Taylor Stacy L SVP and General Counsel | 2020-07-24 | Option exercise | +1,771 | $6.55 | $11,600 | 4,180 | D: show line 2 in the form |
| Taylor Stacy L SVP and General Counsel | 2020-07-24 | Sale | −2,880 | $36.03 | $103,766 | 1,300 | D: show line 3 in the form |
| Open-market sales · 2,880 sh · avg $36.03 · $103,766 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2020-07-24 | Option exercise · Stock Option (Right to Buy) | −1,109 | 38,363 | D: show line 4 in the form | ||
| Taylor Stacy L SVP and General Counsel | 2020-07-24 | Option exercise · Stock Option (Right to Buy) | −1,771 | 35,417 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…